JAK1 pathway inhibitors for the treatment of chronic lung allograft dysfunction
MYPI2025002390A0Undetermined Publication Date: 2020-09-05INCYTE CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025002390
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-03-05
- Filing Date
- 2020-03-05
- Publication Date
- 2020-09-05
Abstract
This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome. [NO FIGURE]
Need to check novelty before this filing date? Find Prior Art
